Why Tilray Stock Is Trading Lower Tuesday

Tilray Brands Inc (NASDAQ: TLRY) shares are trading lower Tuesday after the cannabis company reported fiscal third-quarter results and announced an acquisition of HEXO Corp (NASDAQ:

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower Tuesday after the cannabis company reported fiscal third-quarter results and announced an acquisition of HEXO Corp (NASDAQ:HEXO).

What Happened: Tilray said third-quarter revenue came in at $145.6 million. On a constant currency basis, quarterly revenue totaled $154.2 million, up 2% year-over-year.

Tilray reported a third-quarter loss of 4 cents per share, which was improved from a loss of 8 cents per share year-over-year. 

Tilray ended the quarter with $408.3 million in cash and marketable securities.

“During the quarter, we continued to focus on our highest priorities: sustaining and growing the top-line across core markets and geographies while optimizing the platform to achieve positive free cash flow on an accelerated timeline,” said Irwin Simon, chairman and CEO of Tilray.

“We are executing on both fronts and delivered revenue growth despite challenging market dynamics across Canada, Europe, and the U.S, as well as our 16th consecutive quarter of positive adjusted EBITDA.”

Related Link: Tilray Shares Volatile After Cannabis Company Announces M&A Deal, Q3 Revenue Miss

Tilray reiterated that it expects to achieve positive free cash flow from operations in full-year 2023. 

Tilray also entered into a definitive agreement to acquire HEXO. Tilray will issue HEXO shareholders 0.4352 Tilray shares for each outstanding HEXO share owned, which implies a purchase price of about $1.25 per HEXO share. 

See Also: Tilray Brands Set To Acquire Cannabis Co. HEXO Corp. In $250M Transaction

TLRY Price Action: Tilray has a 52-week high of $6.80 and a 52-week low of $2.28.

The stock was down 6.57% at $2.56 at time of publication, according to Benzinga Pro.

Photo: 7raysmarketing from Pixabay.

Total
0
Shares
Related Posts
Read More

Gold, Precious Metals Dominate Real-World Assets On Blockchain: Is This A Sign Of Things To Come?

In a significant development for the digital assets space, the value of real-world assets (RWAs) on-chain achieved a new milestone, reaching an all-time high of $3.1 billion as of Sept. 1, according to research. This surge in value surpasses the previous record of $2.75 billion set in April 2022 by a notable 13%.

ETH

Read More

FDA Approves Over The Counter Sale Of Opioid Reversal Drug Narcan

Narcan, the prescription nasal spray that reverses opioid overdoses can now be sold over the counter (OTC), said the FDA on Wednesday, reported the NY Times, thereby authorizing a move that has been long-sought by public health officials, treatment experts, families and individuals close to the ongoing opioid crisis.

EBS

Read More

Analysts Weigh In On Applied Materials Earnings Print: What Investors Need To Know

Semiconductor equipment provider Applied Materials, Inc (NASDAQ: AMAT) beat the Street's expectations for its fiscal first quarter. The Santa Clara, California-based company issued upbeat guidance for the current quarter. As a result, several prominent analysts issued notes on the stock.

AMAT